| 1 |
Trotter JF.Liver transplantation around the world[J].Curr Opin Organ Transplant,2017,22(2):123-127.
|
| 2 |
Tector AJ, Mangus RS, Chestovich P, et al.Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival[J].Ann Surg, 2006, 244(3):439-450.
|
| 3 |
中国医师协会器官移植医师分会, 中华医学会器官移植学分会,中华医学会外科学分会移植学组, 中国医院协会器官获取与分配工作委员会.中国心脏死亡捐献器官评估与应用专家共识(2022 版)[J/CD].中华移植杂志:电子版, 2022, 16(6): 321-328.
|
| 4 |
Pandya K, Sastry V, Panlilio MT, et al.Differential impact of extended criteria donors after brain death or circulatory death in adult liver transplantation[J].Liver Transpl,2020,26(12):1603-1617.
|
| 5 |
Parente A, Sun K, Dutkowski P, et al.Routine utilization of machine perfusion in liver transplantation:ready for prime time?[J].World J Gastroenterol,2024,30(11):1488-1493.
|
| 6 |
Kim SC, Foley DP.Strategies to improve the utilization and function of DCD livers[J].Transplantation,2024,108(3):625-633.
|
| 7 |
王彦峰, 王云昊.肝脏机械灌注研究进展[J].中华器官移植杂志,2023,44(8):449-453.
|
| 8 |
de Meijer VE, Fujiyoshi M, Porte RJ. Ex situ machine perfusion strategies in liver transplantation[J].J Hepatol,2019,70(1):203-205.
|
| 9 |
Schlegel A, Mergental H, Fondevila C, et al.Machine perfusion of the liver and bioengineering[J].J Hepatol, 2023, 78(6): 1181-1198.
|
| 10 |
汪恺, 苏仁义, 王周城, 徐骁.“机械灌注+”视阈下扩大标准供肝的修复与功能提升[J].中华消化外科杂志, 2022,21(1):74-78.
|
| 11 |
Ceresa CDL, Nasralla D, Pollok JM, et al.Machine perfusion of the liver: applications in transplantation and beyond [J].Nat Rev Gastroenterol Hepatol,2022,19(3):199-209.
|
| 12 |
Guo Z, Zhao Q, Jia Z, et al.A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease[J].J Hepatol,2023,79(2):394-402.
|
| 13 |
Huang C, Huang S, Tang Y, et al.Prospective, single-centre,randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of endstage liver disease[J].BMJ Open,2020,10(5): e035374.
|
| 14 |
Balshem H, Helfand M,Schünemann HJ,et al.GRADE guidelines:3.Rating the quality of evidence[J].J Clin Epidemiol, 2011, 64(4):401-406.
|
| 15 |
Karangwa S, Panayotova G, Dutkowski P, et al.Hypothermic machine perfusion in liver transplantation[J].Int J Surg, 2020,82S:44-51.
|
| 16 |
Guarrera JV, Henry SD, Samstein B, et al.Hypothermic machine preservation in human liver transplantation: the first clinical series[J].Am J Transplant,2010,10(2):372-381.
|
| 17 |
Panayotova GG, Lunsford KE, Quillin RC 3rd, et al.Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation: a randomized, open-label, clinical trial[J].Hepatology,2024,79(5):1033-1047.
|
| 18 |
van Rijn R, Schurink IJ, de Vries Y, et al.Hypothermic machine perfusion in liver transplantation-a randomized trial[J].N Engl J Med,2021,384(15):1391-1401.
|
| 19 |
Schlegel A, Mueller M, Muller X, et al.A multicenter randomizedcontrolled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation[J].J Hepatol, 2023, 78(4):783-793.
|
| 20 |
Ravaioli M, Germinario G, Dajti G, et al.Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-a randomized clinical trial[J].Am J Transplant,2022,22(10):2401-2408.
|
| 21 |
Czigany Z, Pratschke J, Froněk J, et al.Hypothermic oxygenated machine perfusion reduces early allograft injury and improves posttransplant outcomes in extended criteria donation liver transplantation from donation after brain death:results from a multicenter randomized controlled trial (HOPE ECD-DBD)[J].Ann Surg,2021,274(5):705-712.
|
| 22 |
Grᶏt M, Morawski M, Zhylko A, et al.Routine end-ischemic hypothermic oxygenated machine perfusion in liver transplantation from donors after brain death: a randomized controlled trial[J].Ann Surg,2023,278(5):662-668.
|
| 23 |
Brüggenwirth IMA, Lantinga VA, Rayar M, et al.Prolonged dual hypothermic oxygenated machine preservation (DHOPE-PRO) in liver transplantation: study protocol for a stage 2, prospective, dualarm, safety and feasibility clinical trial[J].BMJ Open Gastroenterol,2022,9(1): e000842.
|
| 24 |
Ramos P, Williams P,Salinas J,et al.Abdominal organ preservation solutions in the age of machine perfusion[J].Transplantation,2023,107(2):326-340.
|
| 25 |
Dutkowski P, Polak WG, Muiesan P, et al.First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an internationalmatched case analysis[J].Ann Surg, 2015, 262(5): 764-770;discussion 770-771.
|
| 26 |
Brüggenwirth IMA, Lantinga VA, Lascaris B, et al.Prolonged hypothermic machine perfusion enables daytime liver transplantationan IDEAL stage 2 prospective clinical trial[J].EClinicalMedicine,2024,68:102411.
|
| 27 |
Sousa Da Silva RX, Weber A, Dutkowski P, et al.Machine perfusion in liver transplantation[J].Hepatology, 2022, 76(5):1531-1549.
|
| 28 |
van Leeuwen OB, Bodewes SB, Lantinga VA, et al.Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers[J].Am J Transplant,2022,22(6):1658-1670.
|
| 29 |
de Vries Y, Berendsen TA, Fujiyoshi M, et al.Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective,single-arm study (DHOPE-COR-NMP trial)[J].BMJ Open,2019,9(8): e028596.
|
| 30 |
Patrono D, Catalano G, Rizza G, et al.Perfusate analysis during dual hypothermic oxygenated machine perfusion of liver grafts:correlations with donor factors and early outcomes [ J ].Transplantation,2020,104(9):1929-1942.
|
| 31 |
Schlegel A, Muller X, Mueller M, et al.Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation[J].EBioMedicine,2020,60:103014.
|
| 32 |
Muller X, Schlegel A, Kron P, et al.Novel real-time prediction of liver graft function during hypothermic oxygenated machine perfusion before liver transplantation[J].Ann Surg, 2019, 270(5): 783-790.
|
| 33 |
Eden J, Thorne AM, Bodewes SB, et al.Assessment of liver graft quality during hypothermic oxygenated perfusion: the first international validation study[J].J Hepatol, 2024: S0168-8278(24)02543-1.
|
| 34 |
Minor T, von Horn C, Zlatev H, et al.Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts.A randomized controlled trial[J].Clin Transl Sci, 2022, 15(12):2918-2927.
|
| 35 |
van Leeuwen OB, de Vries Y, Fujiyoshi M, et al.Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo-and normothermic machine perfusion: a prospective clinical trial[J].Ann Surg,2019,270(5):906-914.
|
| 36 |
van Leeuwen OB, Bodewes SB, Porte RJ, et al.Excellent long-term outcomes after sequential hypothermic and normothermic machine perfusion challenges the importance of functional donor warm ischemia time in DCD liver transplantation[J].J Hepatol, 2023, 79(6):e244-e245.
|
| 37 |
Guarrera JV, Henry SD, Samstein B, et al.Hypothermic machine preservation facilitates successful transplantation of “ orphan ”extended criteria donor livers[J].Am J Transplant, 2015, 15(1):161-169.
|
| 38 |
Eden J, Brüggenwirth IMA, Berlakovich G, et al.Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1 202 donor livers in a real-world setting (HOPEREAL study)[J].J Hepatol,2025,82(1):97-106.
|
| 39 |
Tang G, Zhang L, Zhou R.Comment on “Machine perfusion techniques for liver transplantation-a meta-analysis of the first seven randomized-controlled trials”[J].J Hepatol, 2024, 80(3): e114-e115.
|
| 40 |
Tang G, Zhang L,Xia L,et al.Hypothermic oxygenated perfusion in liver transplantation: a meta-analysis of randomized controlled trials and matched studies[J].Int J Surg,2024,110(1):464-477.
|
| 41 |
Tang G, Zhang L, Zhou R.A commentary on “Effects of machine perfusion strategies on different donor types in liver transplantation: a systematic review and meta-analysis”[J].Int J Surg, 2023, 109(12):4377-4379.
|
| 42 |
Liang A, Cheng W, Cao P, et al.Effects of machine perfusion strategies on different donor types in liver transplantation:a systematic review and meta-analysis[J].Int J Surg, 2023, 109(11): 3617-3630.
|
| 43 |
Tingle SJ, Dobbins JJ, Thompson ER, et al.Machine perfusion in liver transplantation[J].Cochrane Database Syst Rev,2023,9(9):CD014685.
|
| 44 |
Parente A, Tirotta F,Pini A,et al.Machine perfusion techniques for liver transplantation-a meta-analysis of the first seven randomizedcontrolled trials[J].J Hepatol,2023,79(5):1201-1213.
|
| 45 |
Czigany Z, Uluk D, Pavicevic S, et al.Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantationlong-term follow-up of a multicenter randomized controlled trial[J].Hepatol Commun,2024,8(2): e0376.
|
| 46 |
Olthoff KM, Kulik L, Samstein B, et al.Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors[J].Liver Transpl, 2010, 16(8):943-949.
|
| 47 |
Liang A, Cheng W, Cao P, et al.Effects of machine perfusion strategies on different donor types in liver transplantation:a systematic review and meta-analysis[J].Int J Surg, 2023, 109(11): 3617-3630.
|
| 48 |
Maspero M, Ali K, Cazzaniga B, et al.Acute rejection after liver transplantation with machine perfusion versus static cold storage: a systematic review and meta-analysis[J].Hepatology,2023,78(3):835-846.
|
| 49 |
Liang A, Zhang L, Jia J, et al.The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution[J].Hepatobiliary Surg Nutr, 2023, 12(5):785-789.
|
| 50 |
Rossignol G, Muller X, Ruiz M, et al.HOPE mitigates ischemiareperfusion injury in ex-situ split grafts: a comparative study with living donation in pediatric liver transplantation[J].Transpl Int,2024,37:12686.
|
| 51 |
Rossignol G, Muller X, Hervieu V, et al.Liver transplantation of partial grafts after ex situ splitting during hypothermic oxygenated perfusion-The HOPE-Split pilot study[J].Liver Transpl, 2022, 28(10):1576-1587.
|
| 52 |
Mabrut JY, Lesurtel M, Muller X, et al. Ex vivo liver splitting and hypothermic oxygenated machine perfusion: technical refinements of a promising preservation strategy in split liver transplantation [J].Transplantation,2021,105(8): e89-e90.
|
| 53 |
Marecki H, Bozorgzadeh A, Porte RJ, et al.Liver ex situ machine perfusion preservation: a review of the methodology and results of large animal studies and clinical trials[J].Liver Transpl, 2017, 23(5):679-695.
|
| 54 |
Quintini C, Martins PN, Shah S, et al.Implementing an innovated preservation technology:the American Society of Transplant Surgeons′(ASTS) Standards Committee White Paper on ex situ liver machine perfusion[J].Am J Transplant,2018,18(8):1865-1874.
|
| 55 |
Martins PN, Buchwald JE, Mergental H, et al.The role of normothermic machine perfusion in liver transplantation[J].Int J Surg,2020,82S:52-60.
|
| 56 |
Nasralla D, Coussios CC, Mergental H, et al.A randomized trial of normothermic preservation in liver transplantation[J].Nature,2018,557(7703):50-56.
|
| 57 |
Krendl FJ, Cardini B, Laimer G, et al.Normothermic liver machine perfusion and successful transplantation of split liver grafts:from proof of concept to clinical implementation[J].Transplantation, 2024,108(6):1410-1416.
|
| 58 |
Clavien PA, Dutkowski P, Mueller M, et al.Transplantation of a human liver following 3 days of ex situ normothermic preservation[J].Nat Biotechnol,2022,40(11):1610-1616.
|
| 59 |
Kathirvel M, Nasralla D, Iype S, et al.Salvage of a right-extended split liver graft using ex situ normothermic machine perfusion-a new therapeutic horizon[J].Transplantation, 2022, 106(6): e320-e321.
|
| 60 |
Melandro F, De Carlis R, Torri F, et al.Viability criteria during liver ex-situ normothermic and hypothermic perfusion[J].Medicina(Kaunas),2022,58(10):1434.
|
| 61 |
Markmann JF, Abouljoud MS, Ghobrial RM, et al.Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial[J].JAMA Surg,2022,157(3):189-198.
|
| 62 |
Guo Z, Zhao Q, Jia Z, et al.A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease[J].J Hepatol,2023,79(2):394-402.
|
| 63 |
Mergental H, Laing RW, Kirkham AJ, et al.Transplantation of discarded livers following viability testing with normothermic machine perfusion[J].Nat Commun,2020,11(1):2939.
|
| 64 |
Mergental H, Laing RW, Kirkham AJ, et al.Discarded livers tested by normothermic machine perfusion in the VITTAL trial: secondary end points and 5-year outcomes[J].Liver Transpl, 2024, 30(1):30-45.
|
| 65 |
Laing RW, Mergental H, Yap C, et al.Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, nonrandomised, prospective, single-arm trial[J].BMJ Open, 2017, 7(11): e017733.
|
| 66 |
Brüggenwirth IMA, de Meijer VE, Porte RJ, et al.Viability criteria assessment during liver machine perfusion [J].Nat Biotechnol,2020,38(11):1260-1262.
|
| 67 |
Banan B, Watson R, Xu M, et al.Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers[J].Liver Transpl,2016,22(7):979-993.
|
| 68 |
Boteon YL, Attard J, Boteon APCS, et al.Manipulation of lipid metabolism during normothermic machine perfusion:effect of defatting therapies on donor liver functional recovery[J].Liver Transpl,2019,25(7):1007-1022.
|
| 69 |
Abbas SH, Ceresa CDL, Hodson L, et al.Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study[J].Trials, 2024, 25(1):386.
|
| 70 |
Hefler J, Leon-Izquierdo D, Marfil-Garza BA, et al.Long-term outcomes after normothermic machine perfusion in liver transplantation-experience at a single North American center[J].Am J Transplant,2023,23(7):976-986.
|
| 71 |
Robinson T, Vargas PA, Yemini R, et al.Are we on track to increase organ utilization? An analysis of machine perfusion preservation for liver transplantation in the United States[J].Artif Organs,2024,48(11):1275-1287.
|
| 72 |
MacConmara M, Hanish SI, Hwang CS, et al.Making every liver count: increased transplant yield of donor livers through normothermic machine perfusion[J].Ann Surg,2020,272(3):397-401.
|
| 73 |
Ghinolfi D, Rreka E, De Tata V, et al.Pilot, open, randomized,prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors[J].Liver Transpl, 2019, 25(3):436-449.
|
| 74 |
Quintini C, Del Prete L, Simioni A, et al.Transplantation of declined livers after normothermic perfusion[J].Surgery,2022,171(3):747-756.
|
| 75 |
Guo Z, Luo T, Mo R, et al.Ischemia-free organ transplantation-a review[J].Curr Opin Organ Transplant,2022,27(4):300-304.
|
| 76 |
Huang C, Huang S, Tang Y, et al.Prospective, single-centre,randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of endstage liver disease[J].BMJ Open,2020,10(5): e035374.
|
| 77 |
Guo Z, Zhao Q, Huang S, et al.Ischaemia-free liver transplantation in humans: a first-in-human trial[J].Lancet Reg Health West Pac,2021,16:100260.
|
| 78 |
Zhang Z, Tang Y, Zhao Q, et al.Association of perfusion characteristics and posttransplant liver function in ischemia-free liver transplantation[J].Liver Transpl,2020,26(11):1441-1454.
|
| 79 |
Tang Y, Wang T, Ju W, et al.Ischemic-free liver transplantation reduces the recurrence of hepatocellular carcinoma after liver transplantation[J].Front Oncol,2021,11:773535.
|
| 80 |
Lin J, Li Y, Fang T, Wang T, et al.Substantial decline of organ preservation fluid contamination following adoption of ischemia-free liver transplantation: a post-hoc analysis[J].Int J Surg,2024,110(5):2855-2864.
|
| 81 |
Chen M, Chen Z, Lin X, et al.Application of ischaemia-free liver transplantation improves prognosis of patients with steatotic donor livers-a retrospective study[J].Transpl Int, 2021, 34(7): 1261-1270.
|
| 82 |
Banker A, Bhatt N, Rao PS, et al.A review of machine perfusion strategies in liver transplantation[J].J Clin Exp Hepatol, 2023, 13(2):335-349.
|
| 83 |
Karimian N, Raigani S, Huang V, et al.Subnormothermic machine perfusion of steatotic livers results in increased energy charge at the cost of anti-oxidant capacity compared to normothermic perfusion[J].Metabolites,2019,9(11):246.
|
| 84 |
Ciria R, Ayllon-Teran MD, González-Rubio S, et al.Rescue of discarded grafts for liver transplantation by ex vivo subnormothermic and normothermic oxygenated machine perfusion: first experience in Spain[J].Transplant Proc,2019,51(1):20-24.
|
| 85 |
Martins PN, Rizzari MD, Ghinolfi D, et al.Design, analysis, and pitfalls of clinical trials using ex situ liver machine perfusion: the international liver transplantation society consensus guidelines[J].Transplantation,2021,105(4):796-815.
|
| 86 |
于欣雨, 郭志勇.2020 国际肝移植协会(ILTS)肝脏机械灌注共识——专家解读[J/CD].实用器官移植电子杂志, 2022, 10(3):201-206.
|
| 87 |
Karangwa SA, Dutkowski P, Fontes P, et al.Machine perfusion of donor livers for transplantation: a proposal for standardized nomenclature and reporting guidelines[J].Am J Transplant, 2016,16(10):2932-2942.
|
| 88 |
op den Dries S, Westerkamp AC, Karimian N, et al.Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures [ J].J Hepatol,2014,60(6):1172-1179.
|
| 89 |
Ghinolfi D, Pezzati D,Rreka E, et al.Transient cold storage prior to normothermic liver perfusion may facilitate adoption of a novel technology[J].Liver Transpl,2019,25(10):1503-1513.
|
| 90 |
Mathis S, Weissenbacher A, Putzer G, et al.Interleukin-6 levels during normothermic machine perfusion impact postreperfusion hemodynamics of liver graft recipients: a prospective single-center observational study[J].Transplantation, 2024, 108(5): 1166-1171.
|
| 91 |
Cox DRA, Lee E, Wong BKL, McClure T, et al.Graft-derived cfDNA monitoring in plasma and bile during normothermic machine perfusion in liver transplantation is feasible and a potential tool for assessing graft viability[J].Transplantation, 2024, 108(4): 958-962.
|
| 92 |
Meszaros AT, Hofmann J, Buch ML, et al.Mitochondrial respiration during normothermic liver machine perfusion predicts clinical outcome[J].EBioMedicine,2022,85:104311.
|
| 93 |
Liu J, Martins PN, Bhat M, et al.Biomarkers and predictive models of early allograft dysfunction in liver transplantation-a systematic review of the literature, meta-analysis, and expert panel recommendations[J].Clin Transplant,2022,36(10): e14635.
|
| 94 |
Dingfelder J, Rauter L, Berlakovich GA, et al.Biliary viability assessment and treatment options of biliary injury during normothermic liver perfusion-a systematic review[J].Transpl Int, 2022, 35:10398.
|